|
Lipids and Lipid Disorders
Citations 1-10 of 225 total displayed.
|
Most recent content
(9 Apr 2008):
|
- Original Contributions
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
- Barbara V. Howard; Mary J. Roman; Richard B. Devereux; Jerome L. Fleg; James M. Galloway; Jeffrey A. Henderson; Wm. James Howard; Elisa T. Lee; Mihriye Mete; Bryce Poolaw; Robert E. Ratner; Marie Russell; Angela Silverman; Mario Stylianou; Jason G. Umans; Wenyu Wang; Matthew R. Weir; Neil J. Weissman; Charlton Wilson; Fawn Yeh; Jianhui Zhu
JAMA 2008; 299: 1678-1689.
[Abstract]
[Full text]
[PDF]
[ JAMA Report Video ] [ Author in the Room ]
- Original Contributions
Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease: The EPIC Randomized Controlled Trials
- Brian G. Feagan; William J. Sandborn; Ulrich Mittmann; Simon Bar-Meir; Geert D’Haens; Marc Bradette; Albert Cohen; Chrystian Dallaire; Terry P. Ponich; John W. D. McDonald; Xavier Hébuterne; Pierre Paré; Pavel Klvana; Yaron Niv; Sandro Ardizzone; Olga Alexeeva; Alaa Rostom; Gediminas Kiudelis; Johannes Spleiss; Denise Gilgen; Margaret K. Vandervoort; Cindy J. Wong; Guang Yong Zou; Allan Donner; Paul Rutgeerts
JAMA 2008; 299: 1690-1697.
[Abstract]
[Full text]
[PDF]
- Editorials
The Great Debate of 2008—How Low to Go in Preventive Cardiology?
- Eric D. Peterson; Tracy Y. Wang
JAMA 2008; 299: 1718-1720.
[Extract]
[Full text]
[PDF]
|
Past content
(since Feb 1998):
|
- Commentaries
Surrogate End Points and FDA Approval: A Tale of 2 Lipid-Altering Drugs
- Bruce M. Psaty; Thomas Lumley
JAMA 2008; 299: 1474-1476.
[Extract]
[Full text]
[PDF]
- Original Contributions
Large-Scale Analysis of Association Between LRP5 and LRP6 Variants and Osteoporosis
- Joyce B. J. van Meurs; Thomas A. Trikalinos; Stuart H. Ralston; Susana Balcells; Maria Luisa Brandi; Kim Brixen; Douglas P. Kiel; Bente L. Langdahl; Paul Lips; Östen Ljunggren; Roman Lorenc; Barbara Obermayer-Pietsch; Claes Ohlsson; Ulrika Pettersson; David M. Reid; Francois Rousseau; Serena Scollen; Wim Van Hul; Lidia Agueda; Kristina Åkesson; Lidia I. Benevolenskaya; Serge L. Ferrari; Göran Hallmans; Albert Hofman; Lise Bjerre Husted; Marcin Kruk; Stephen Kaptoge; David Karasik; Magnus K. Karlsson; Mattias Lorentzon; Laura Masi; Fiona E. A. McGuigan; Dan Mellström; Leif Mosekilde; Xavier Nogues; Huibert A. P. Pols; Jonathan Reeve; Wilfried Renner; Fernando Rivadeneira; Natasja M. van Schoor; Kurt Weber; John P. A. Ioannidis; André G. Uitterlinden; for the GENOMOS Study
JAMA 2008; 299: 1277-1290.
[Abstract]
[Full text]
[PDF]
[ eFigure and eTables ]
- Research Letters
Plasma Anandamide Concentration and Pregnancy Outcome in Women With Threatened Miscarriage
- Osama M. H. Habayeb; Anthony H. Taylor; Mark Finney; Mark D. Evans; Justin C. Konje
JAMA 2008; 299: 1135-1136.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Controversies Surround Heart Drug Study: Questions About Vytorin and Trial Sponsors' Conduct
- Mike Mitka
JAMA 2008; 299: 885-887.
[Extract]
[Full text]
[PDF]
- Commentaries
Critical Lessons From the ENHANCE Trial
- Philip Greenland; Donald Lloyd-Jones
JAMA 2008; 299: 953-955.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Therapies Aim to Boost "Good" Cholesterol
- Mike Mitka
JAMA 2008; 299: 509-510.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Lower Cholesterol Levels
- Bridget M. Kuehn
JAMA 2008; 299: 399-c.
[Extract]
[Full text]
[PDF]
|
|
